| Cancer-specific loss of p53 leads to a modulation of myeloid and T cell responses J Blagih, F Zani, P Chakravarty, M Hennequart, S Pilley, S Hobor, ... Cell reports 30 (2), 481-496. e6, 2020 | 133 | 2020 |
| The dietary sweetener sucralose is a negative modulator of T cell-mediated responses F Zani, J Blagih, T Gruber, MD Buck, N Jones, M Hennequart, CL Newell, ... Nature 615 (7953), 705-711, 2023 | 32 | 2023 |
| Mutant p53 in cell-cell interactions S Pilley, TA Rodriguez, KH Vousden Genes & development 35 (7-8), 433-448, 2021 | 32 | 2021 |
| The impact of physiological metabolite levels on serine uptake, synthesis and utilization in cancer cells M Hennequart, CF Labuschagne, M Tajan, SE Pilley, EC Cheung, ... Nature Communications 12 (1), 6176, 2021 | 23 | 2021 |
| ALDH1L2 regulation of formate, formyl-methionine, and ROS controls cancer cell migration and metastasis M Hennequart, SE Pilley, CF Labuschagne, J Coomes, L Mervant, ... Cell Reports 42 (6), 2023 | 13 | 2023 |
| Loss of attachment promotes proline accumulation and excretion in cancer cells SE Pilley, M Hennequart, A Vandekeere, J Blagih, NM Legrave, SM Fendt, ... Science Advances 9 (36), eadh2023, 2023 | 4 | 2023 |
| The aging tumor metabolic microenvironment SE Pilley, E Esparza, PJ Mullen Current Opinion in Biotechnology 84, 102995, 2023 | 1 | 2023 |
| A metabolic atlas of mouse aging SE Pilley, D Awad, D Latumalea, E Esparza, L Zhang, X Shi, M Unfried, ... bioRxiv, 2024.05. 04.592445, 2024 | | 2024 |
